Hanxi Zhao

868 total citations
23 papers, 656 citations indexed

About

Hanxi Zhao is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Otorhinolaryngology. According to data from OpenAlex, Hanxi Zhao has authored 23 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Otorhinolaryngology. Recurrent topics in Hanxi Zhao's work include Effects of Radiation Exposure (9 papers), Head and Neck Cancer Studies (8 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Hanxi Zhao is often cited by papers focused on Effects of Radiation Exposure (9 papers), Head and Neck Cancer Studies (8 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Hanxi Zhao collaborates with scholars based in China and South Sudan. Hanxi Zhao's co-authors include Wanqi Zhu, Ligang Xing, Peng Xie, Xindong Sun, Jinming Yu, Xiangjiao Meng, Xianguang Zhao, Zheng Fu, Lingling Kong and Jia Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Hanxi Zhao

21 papers receiving 650 citations

Peers

Hanxi Zhao
Wanqi Zhu China
W. K. Hong United States
Sonia Tyagi United States
Ashutosh Pathak United States
Prashasnika Gehlot United States
Wanqi Zhu China
Hanxi Zhao
Citations per year, relative to Hanxi Zhao Hanxi Zhao (= 1×) peers Wanqi Zhu

Countries citing papers authored by Hanxi Zhao

Since Specialization
Citations

This map shows the geographic impact of Hanxi Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanxi Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanxi Zhao more than expected).

Fields of papers citing papers by Hanxi Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanxi Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanxi Zhao. The network helps show where Hanxi Zhao may publish in the future.

Co-authorship network of co-authors of Hanxi Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Hanxi Zhao. A scholar is included among the top collaborators of Hanxi Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanxi Zhao. Hanxi Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Yin, Xiaoyan, Wanqi Zhu, Guangjian Yang, et al.. (2024). Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer. BMC Cancer. 24(1). 486–486. 9 indexed citations
4.
Xie, Jingjing, Jia Li, Peng Xie, et al.. (2023). Efficacy and safety of epigallocatechin-3-gallate in treatment acute severe dermatitis in patients with cancer receiving radiotherapy: a phase I clinical trial. Scientific Reports. 13(1). 13865–13865. 15 indexed citations
5.
Hu, Junping, Na Li, Jinfang Gao, et al.. (2022). The Mechanism of Stem Cell Aging. Stem Cell Reviews and Reports. 18(4). 1281–1293. 35 indexed citations
6.
Zhao, Hanxi, Wanqi Zhu, Xianguang Zhao, et al.. (2022). Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy. JAMA Dermatology. 158(7). 779–779. 47 indexed citations
7.
Zhu, Wanqi, Shuyu Zhang, Xiaolin Li, et al.. (2021). Evaluation of Epigallocatechin-3-Gallate as a Radioprotective Agent During Radiotherapy of Lung Cancer Patients: A 5-Year Survival Analysis of a Phase 2 Study. Frontiers in Oncology. 11. 686950–686950. 9 indexed citations
8.
Zhu, Weiliang & Hanxi Zhao. (2020). A Randomized, Double-blind, Placebo-controlled Phase 2 Trial of Epigallocatechin-gallate in the Prevention of Radiation-induced Dermatitis. International Journal of Radiation Oncology*Biology*Physics. 108(3). S12–S12. 4 indexed citations
10.
Li, Xiaoling, Ligang Xing, Yujun Zhang, et al.. (2019). Phase II Trial of Epigallocatechin-3-Gallate in Acute Radiation-Induced Esophagitis for Esophagus Cancer. Journal of Medicinal Food. 23(1). 43–49. 26 indexed citations
11.
Zhu, Wanqi, Mei Hui, Jia Li, et al.. (2019). Epigallocatechin-3-gallate mouthwash protects mucosa from radiation-induced mucositis in head and neck cancer patients: a prospective, non-randomised, phase 1 trial. Investigational New Drugs. 38(4). 1129–1136. 34 indexed citations
12.
Zhu, Wanqi, Jia Li, Hanxi Zhao, et al.. (2016). Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapy. Oncotarget. 7(30). 48607–48613. 45 indexed citations
13.
Zhao, Hanxi, et al.. (2015). Correlation of EGFR gene amplification with invasion and metastasis of non-small cell lung cancer. Genetics and Molecular Research. 14(3). 11006–11012. 10 indexed citations
14.
Zhao, Hanxi, et al.. (2015). Relationship of EGFR DNA methylation with the severity of non-small cell lung cancer. Genetics and Molecular Research. 14(4). 11915–11923. 6 indexed citations
15.
Zhao, Hanxi, Peng Xie, Xiaolin Li, et al.. (2015). A prospective phase II trial of EGCG in treatment of acute radiation-induced esophagitis for stage III lung cancer. Radiotherapy and Oncology. 114(3). 351–356. 57 indexed citations
16.
Meng, Xiangjiao, Zhaoqin Huang, Dianbin Mu, et al.. (2015). Expression of Human Epidermal Growth Factor Receptor-2 in Resected Rectal Cancer. Medicine. 94(47). e2106–e2106. 9 indexed citations
17.
Zhao, Hanxi, Wanqi Zhu, Jia Li, et al.. (2015). Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy. British Journal of Radiology. 89(1058). 20150665–20150665. 80 indexed citations
19.
Xie, Peng, Minghuan Li, Hanxi Zhao, et al.. (2011). 18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis. Journal of Cancer Research and Clinical Oncology. 137(7). 1085–1093. 82 indexed citations
20.
Xie, Peng, Jinbo Yue, Hanxi Zhao, et al.. (2009). Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma. Journal of Cancer Research and Clinical Oncology. 136(6). 883–889. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026